Microbiology & Infectious Diseases

Approximately 3 million adults aged 80 and over and care home residents are set to get the RSV vaccine on the NHS, it announced on 2nd April 2026.

New antibiotics have not reduced mortality in drug-resistant infections, with treatment delays and mismatched therapy still driving poor outcomes.

New research defines RSV viral shedding timelines, showing a short infectious window and key immune responses to guide prevention.

Ending CDC-funded HIV testing could raise infections by 10%, with rural areas most affected, highlighting the key role of early diagnosis.

Metagenomic analysis reveals Treponema and microbial dysbiosis in children with noma, a poorly understood, devastating childhood disease.

Fluvoxamine may reduce long COVID fatigue and boost quality of life, while metformin shows no benefit in adults with persistent post-COVID symptoms.

A new AI platform offers free drug discovery tools to global health researchers, aiming to speed up treatments for malaria, tuberculosis, and more.

London measles outbreak prompts calls for stronger vaccination efforts, with low uptake and inequalities driving rising case numbers.